Tomorrow Investor

First Atlantic Nickel & Cobalt Produces High Grade Alloy Concentrate Up to 71.9% Nickel and 1.76% Cobalt from Its Pipestone XL Nickel-Cobalt Alloy Project, Using Its First-Ever ONSHORE MAX (Magnetic Alloy eXtraction) Recovery & Concentration Process, Unveiled at the Fastmarkets Lithium Supply & Battery Raw Materials Conference, Las Vegas, USA

First Atlantic Nickel's High-Grade Cobalt & Nickel Concentrate Production | GlobeNewsWire

First Atlantic announces ONSHORE MAX test work upgraded RPM Zone rock samples into a 67.4% nickel concentrate, grading up to 71.9% nickel and 1.76% cobalt.

This excerpt is quoted from the original release. Read the full announcement on GlobeNewsWire.

Brief Summary

First Atlantic Nickel & Cobalt has officially announced the successful results of its recent test work using the ONSHORE MAX (Magnetic Alloy eXtraction) process at the Pipestone XL Nickel-Cobalt Alloy Project. The test upgraded RPM Zone rock samples into an impressive 67.4% nickel concentrate, achieving grades of up to 71.9% nickel and 1.76% cobalt. This marks a significant milestone in their efforts towards sustainable and efficient production of high-grade alloy concentrate.

  • Ongoing Innovation: Introduction of new recovery technology.
  • Market Implications: Increased production capability for future supply chains.
  • Environmental Considerations: Emphasis on sustainable practices in alloy production.

Why it matters: This advancement positions First Atlantic as a notable player in the nickel and cobalt sector, catering to growing demand from battery manufacturers.

Read the Full Article

This is a summary of the press release. For the complete article and any additional details, please visit the original source.

Read Full Article

Attribution: Original press release by GlobeNewsWire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.

Tomorrow Investor
The Tomorrow Investor

Markets research for retail investors

Independent coverage of small-cap equities, biotech catalysts, and emerging market opportunities.